SCPH logo

scPharmaceuticals (SCPH)

Profile

Full Name

scPharmaceuticals Inc.

Ticker Symbol

SCPH

Exchange

NASDAQ

Country

United States

IPO

November 17, 2017

Indexes

Not included

Employees

162

Key Details

Price

$2.32(+15.14%)

Market cap

$116.66M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$36.33M(+167.28% YoY)

Annual EPS

-$1.91(-34.51% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 20, 25 Maxim Group
Buy
Mar 20, 25 HC Wainwright & Co.
Buy
Mar 7, 25 HC Wainwright & Co.
Buy
Mar 3, 25 HC Wainwright & Co.
Buy
Nov 14, 24 HC Wainwright & Co.
Buy
Nov 14, 24 Craig-Hallum
Buy
Aug 19, 24 HC Wainwright & Co.
Buy
May 15, 24 HC Wainwright & Co.
Buy
Mar 14, 24 HC Wainwright & Co.
Buy
Sep 7, 23 Craig-Hallum
Buy

Institutional Ownership

  • What is the ticker symbol for scPharmaceuticals?
  • Does scPharmaceuticals pay dividends?
  • What sector is scPharmaceuticals in?
  • What industry is scPharmaceuticals in?
  • What country is scPharmaceuticals based in?
  • When did scPharmaceuticals go public?
  • Is scPharmaceuticals in the S&P 500?
  • Is scPharmaceuticals in the NASDAQ 100?
  • Is scPharmaceuticals in the Dow Jones?
  • When was scPharmaceuticals's last earnings report?
  • When does scPharmaceuticals report earnings?
  • Should I buy scPharmaceuticals stock now?

What is the ticker symbol for scPharmaceuticals?

The ticker symbol for scPharmaceuticals is NASDAQ:SCPH

Does scPharmaceuticals pay dividends?

No, scPharmaceuticals does not pay dividends

What sector is scPharmaceuticals in?

scPharmaceuticals is in the Healthcare sector

What industry is scPharmaceuticals in?

scPharmaceuticals is in the Biotechnology industry

What country is scPharmaceuticals based in?

scPharmaceuticals is headquartered in United States

When did scPharmaceuticals go public?

scPharmaceuticals's initial public offering (IPO) was on November 17, 2017

Is scPharmaceuticals in the S&P 500?

No, scPharmaceuticals is not included in the S&P 500 index

Is scPharmaceuticals in the NASDAQ 100?

No, scPharmaceuticals is not included in the NASDAQ 100 index

Is scPharmaceuticals in the Dow Jones?

No, scPharmaceuticals is not included in the Dow Jones index

When was scPharmaceuticals's last earnings report?

scPharmaceuticals's most recent earnings report was on Mar 19, 2025

When does scPharmaceuticals report earnings?

The next expected earnings date for scPharmaceuticals is May 14, 2025

Should I buy scPharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page